European Monitoring Centre for Drugs and Drug Addiction
This report provides an update on infectious diseases related to injecting drug use in Europe for the period up to June 2015. The report covers both the EMCDDA Drug-related infectious diseases indicator, which collects data on the situation, and the responses in the area. It includes highlights...
Tags: General public, Health care professionals, NGOs, People living with HIV (PLHIV), People who are/were in prisons, People who use drugs (PUD), Policy makers, Central Europe, Eastern Europe, Northern Europe, Southern Europe, Western Europe, Harm reduction, Policy, Prevention, Treatment, Viral hepatitis
European Monitoring Centre for Drugs and Drug Addiction
The prescription of substitution drugs, such as methadone and buprenorphine, has become a mainstream, first-line treatment for opioid dependence, with around 700 000 of Europe’s 1.3 million problem opioid users receiving substitution treatment today. But a small minority of entrenched opioid...
Tags: Health care professionals, NGOs, People who use drugs (PUD), Policy makers, Central Europe, Eastern Europe, Northern Europe, Southern Europe, Western Europe, Care and support, Harm reduction, Policy, Treatment
European Centre for Disease Prevention and Control and European Monitoring Centre for Drugs and Drug Addiction
This joint guidance report explores good public health practices that can support effective policies to reduce infections. Common blood-borne viruses in this group include HIV, hepatitis B and hepatitis C. These are mainly spread through the sharing of needles, syringes and drug preparation...
Tags: Health care professionals, NGOs, People who use drugs (PUD), Policy makers, Central Europe, Eastern Europe, Northern Europe, Southern Europe, Western Europe, Advocacy, Care and support, Harm reduction, Policy, Prevention, Resource mobilisation, Social issues, Treatment, Viral hepatitis
European Monitoring Centre for Drugs and Drug Addiction
Transmitted through the sharing of needles, syringes and other injecting equipment, hepatitis C is the most common infectious disease among injecting drug users in Europe today.In this analysis, the EMCDDA looks at some of the positive advances in treating the disease, including a new generation...
Tags: Health care professionals, People who use drugs (PUD), Policy makers, Central Europe, Northern Europe, Southern Europe, Western Europe, Care and support, Harm reduction, Prevention, Treatment, Viral hepatitis
The Joint Action on HIV and Co-infection Prevention and Harm Reduction (HA-REACT) addresses existing gaps in the prevention of HIV and other co-infections, especially tuberculosis (TB) and viral hepatitis, among people who inject drugs (PWID). This three-year project was launched in late 2015...
Catherine Cook, Maria Phelan, Gen Sander, Katie Stone, Fionnuala Murphy
Published biennially since 2008, the Global State of Harm Reduction is the leading independent resource monitoring the international harm reduction response.
The April 2016 UN General Assembly Special Session on the World Drug Problem coincides with the tenth anniversary of the start of...
Tags: General public, Health care professionals, NGOs, People who use drugs (PUD), Global, Advocacy, Harm reduction, Human rights, Treatment
This report is part of the European Union co-funded project “Improving Prison Conditions by Strengthening Infectious Disease Monitoring”, led by Harm Reduction International. The project aims to reduce ill treatment of people in detention and improve prison conditions through more comprehensive...
Tags: General public, Health care professionals, People who are/were in prisons, Policy makers, Central Europe, Eastern Europe, Northern Europe, Southern Europe, Western Europe, Harm reduction, Human rights, Laws and regulations, Monitoring and Evaluation, Treatment, Tubercolosis
Dr Ann Sullivan, Dr Emma Devitt, Ruth Lowbury (second edition) (based on first edition by Dr Rachel Baggaley)
The booklet provides essential information for healthcare professionals in secondary care on: -the clinical diagnosis of HIV in non-HIV specialist settings, with photographs -how to offer an HIV test and give results -barriers to HIV testing for clinicians & patients / strategies for...
Tags: Health care professionals, Global, Western Europe, Epidemiology, Testing and counselling, Treatment
Šī brošūra par HIV infekcijas terapijas maiņu un zāļu rezistenci paskaidros: 1) Kad un kāpēc ārstēšana būtu jāmaina? 2) Kādus testus izmanto un ko nozīmē to rezultāti? 3) Kā piemeklēt zāles nākošajai kombinācijai? 4) Kā nostiprināt pārliecību par to, ka nākošā ārstēšana iedarbosies labāk?
Tags: People living with HIV (PLHIV), Eastern Europe, WHO European region, Treatment
This technical brief summarizes essential information and existing WHO recommendations for HIV prevention, diagnosis, treatment and care among transgender populations.
Tags: Health care professionals, Policy makers, Global, Care and support, Treatment
